Medicare Rx Payment Method Deters Hospital Use Of High-Cost Drugs – BIO

Basing Medicare reimbursement for hospital-administered drugs on a single cost-to-charge ratio will lead hospitals to stop providing higher cost drugs and biological products, Alkermes CEO Richard Pops told the Senate Appropriations/HHS Subcommittee Jan. 30

More from Archive

More from Pink Sheet